Trial Profile
Randomized Control Trial: Two Different Antibiotics Versus One Antibiotic for Pediatric Perforated Appendicitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Jan 2024
Price :
$35
*
At a glance
- Drugs Piperacillin/tazobactam (Primary) ; Ceftriaxone/metronidazole
- Indications Bacterial infections
- Focus Therapeutic Use
- 10 Jan 2024 Status changed from active, no longer recruiting to completed.
- 22 Apr 2022 Planned End Date changed from 22 Dec 2020 to 8 Feb 2023.
- 22 Apr 2022 Status changed from recruiting to active, no longer recruiting.